|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-1-9
|
|
pubmed:abstractText |
Androgens and other drugs that reduce plasma concentrations of high density lipoprotein (HDL) cholesterol are often considered to be pro-atherogenic. Tibolone lowers HDL-cholesterol by 20% but the clinical significance of this effect is unknown.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0300-0664
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
49-58
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12519412-Carrier Proteins,
pubmed-meshheading:12519412-Cell Culture Techniques,
pubmed-meshheading:12519412-Cholesterol,
pubmed-meshheading:12519412-Cholesterol, HDL,
pubmed-meshheading:12519412-Double-Blind Method,
pubmed-meshheading:12519412-Estrogen Receptor Modulators,
pubmed-meshheading:12519412-Female,
pubmed-meshheading:12519412-Humans,
pubmed-meshheading:12519412-Lipase,
pubmed-meshheading:12519412-Lipids,
pubmed-meshheading:12519412-Liver,
pubmed-meshheading:12519412-Middle Aged,
pubmed-meshheading:12519412-Norpregnenes
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux.
|
|
pubmed:affiliation |
Institüt für Klinische Chemie und Laboratoriumsmedizin, Zentrallaboratorium, Westfälische Wilhelms-Universität Münster, Germany. arnold.voneckardstein@ikc.usz.ch
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
